NO812039L - Fremgangsmaate til fremstilling av protrahert virkende vincamin-tilberedninger, saaledes dannede vincamin-tilberedninger og legemidler inneholdende disse - Google Patents

Fremgangsmaate til fremstilling av protrahert virkende vincamin-tilberedninger, saaledes dannede vincamin-tilberedninger og legemidler inneholdende disse

Info

Publication number
NO812039L
NO812039L NO812039A NO812039A NO812039L NO 812039 L NO812039 L NO 812039L NO 812039 A NO812039 A NO 812039A NO 812039 A NO812039 A NO 812039A NO 812039 L NO812039 L NO 812039L
Authority
NO
Norway
Prior art keywords
vincamine
preparations
acid
preparation
salt
Prior art date
Application number
NO812039A
Other languages
English (en)
Norwegian (no)
Inventor
Satish Chandra Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO812039L publication Critical patent/NO812039L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO812039A 1980-06-23 1981-06-16 Fremgangsmaate til fremstilling av protrahert virkende vincamin-tilberedninger, saaledes dannede vincamin-tilberedninger og legemidler inneholdende disse NO812039L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH480480 1980-06-23

Publications (1)

Publication Number Publication Date
NO812039L true NO812039L (no) 1981-12-28

Family

ID=4282830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812039A NO812039L (no) 1980-06-23 1981-06-16 Fremgangsmaate til fremstilling av protrahert virkende vincamin-tilberedninger, saaledes dannede vincamin-tilberedninger og legemidler inneholdende disse

Country Status (15)

Country Link
EP (1) EP0042818A1 (el)
JP (1) JPS5762277A (el)
KR (1) KR830005853A (el)
AU (1) AU7201781A (el)
DD (1) DD159737A5 (el)
DK (1) DK274081A (el)
ES (1) ES8203891A1 (el)
FI (1) FI811934L (el)
GB (1) GB2078758A (el)
GR (1) GR75708B (el)
IL (1) IL63148A0 (el)
NO (1) NO812039L (el)
NZ (1) NZ197485A (el)
PT (1) PT73238B (el)
ZA (1) ZA814194B (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (el) * 1955-08-08
FR2201898A1 (en) * 1973-05-30 1974-05-03 Sogeras Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders
FR2253507A1 (en) * 1973-12-11 1975-07-04 Houdet Antoine Vincamine administration using delayed release excipient - allowing prolonged action
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
PT66201B (fr) * 1976-02-23 1978-11-07 Corvi Mora E Procede et composition pour la therapeutique des maladies circulatoires cerebrales

Also Published As

Publication number Publication date
PT73238A (de) 1981-07-01
AU7201781A (en) 1982-01-07
ES503263A0 (es) 1982-04-01
EP0042818A1 (de) 1981-12-30
GB2078758A (en) 1982-01-13
NZ197485A (en) 1983-09-30
PT73238B (de) 1983-05-11
IL63148A0 (en) 1981-09-13
DD159737A5 (de) 1983-04-06
JPS5762277A (en) 1982-04-15
ZA814194B (en) 1982-07-28
GR75708B (el) 1984-08-02
FI811934L (fi) 1981-12-24
KR830005853A (ko) 1983-09-14
ES8203891A1 (es) 1982-04-01
DK274081A (da) 1981-12-24

Similar Documents

Publication Publication Date Title
FI87525C (fi) Foerfarande foer framstaellning av en farmaceutisk hartskomposition med kontrollerad foerdroejd frigivning av dextrometorfanhydrobromid
NO792335L (no) Legemiddel-retardform med uopploeselige, poroese diffusjonsovertrekk
JPH0530804B2 (el)
TW200540177A (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
AU2002355624A1 (en) Crystalline composition containing escitalopram
CA2628031C (en) Once-daily administration of central nervous system drugs
MXPA01013046A (es) Formas de administracion oral para administrar una combinacion fija de tramadol y diclofenac.
US4861599A (en) Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use
CN116847831A (zh) 无定形固体分散系的药物组合物及其制备方法
US4369175A (en) Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them
NO140526B (no) Vernevisiranording for sikkerhetshjelm
NO873031L (no) Ionebytterharpiks.
ZA200109547B (en) Taste masked compositions.
IE891263L (en) Azelastine-containing medicaments with controlled release of¹the active substance
NO812039L (no) Fremgangsmaate til fremstilling av protrahert virkende vincamin-tilberedninger, saaledes dannede vincamin-tilberedninger og legemidler inneholdende disse
CZ20014379A3 (cs) Kompozice k maskování chuti a způsob její přípravy
JP6787928B2 (ja) リバスチグミン含有徐放出医薬組成物
US11602507B2 (en) Extended release oral composition of memantine or its salt and its process for the preparation
CN110917164B (zh) 一种苯磺酸米洛巴林缓释片及其制备方法
CN112057427B (zh) 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法
CN112972396A (zh) 一种非布司他控释组合物及其制备方法
KR100602235B1 (ko) 방출제어형 약제학적 조성물의 제조방법
CA2607272A1 (en) Formulations of mast cell stabilizing agents for delivery to the colon
CN116803378B (zh) 一种格列齐特缓释片剂及其制备方法
Verner Formulation and dissolution assessment of a novel repeat action tablet containing a decongestant and an antihistamine